Pitkäranta et al. [51] found that lower virus-induced IFN-γ production in vitro was associated with frequently recurring respiratory infections in children, whereas blocking of Type 2 cytokine expression via prior administration of antibodies to IL-10 and IL-4 reduces symptom severity following respiratory syncytial virus infection [52, 53]. The gene discussed is IL4; the disease is respiratory tract infectious disorder.